Trial Profile
Effect of enoxaparin-sodium on enhanced coagulation induced by crystalloid haemodilution.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2010
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Blood coagulation disorders; Embolism and thrombosis
- Focus Pharmacodynamics
- 23 Dec 2010 New trial record